Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769207 · ClinicalTrials.gov registry record · NA
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
A NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Apple.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03769207: Completed NA study of Atrial Fibrillation and Atrial Flutter, sponsored by Apple.
NCT03769207 is a NA study of Atrial Fibrillation and Atrial Flutter that has completed, run by Apple. The registered enrollment target is 17 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03769207, a NA study of Atrial Fibrillation and Atrial Flutter, has completed, sponsored by Apple.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
Primary Outcome
Detected on ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification
Conditions Studied
Interventions
- DEVICE Ambulatory ECG
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-12-08 |
| Est. Completion | 2019-08-20 |
| Phase | NA |
What the finished NCT03769207 record still lists
NCT03769207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Ambulatory ECG is the first listed.
NCT03769207 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03769207 about?
NCT03769207 is a clinical study titled "Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias". This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.
What is the current status of trial NCT03769207?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-12-08. Estimated completion is 2019-08-20.
What conditions does trial NCT03769207 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter, Arrhythmias, Cardiac.
What interventions are being tested in trial NCT03769207?
The interventions under investigation include: Ambulatory ECG (DEVICE).
Who is sponsoring clinical trial NCT03769207?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03769207 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03769207's enrollment target sits among peer trials
17 195th of 202 higher than 7 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI